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Editorial
Endophenotypes in the genetic research 
of ADHD over the last decade: have they 
lived up to their expectations?
Expert Rev. Neurother. 8(10), 1425–1429 (2008)
“…research into candidate endophenotypes for attention-
deficit/hyperactivity disorder lags somewhat behind, compared 
with similar studies in other psychiatric disorders…”
The endophenotype concept was intro-
duced over 35 years ago in psychiatric 
research [1]. It was observed that, in com-
plex disorders, multiple phenotypes could 
arise from the same genotype, as well as 
that multiple genotypes could give rise 
to the same phenotype. Thus, the direct 
link between genotype and phenotype 
is often only weak. Endophenotypes are 
proposed to intermediate between geno-
type and phenotype, and can be defined as 
‘heritable, quantitative traits that index an 
individual’s liability to develop or mani-
fest a given disease’ [2]. As such, it follows 
that the endophenotype is heritable (and 
familial), in which the same genes partly 
influence the endophenotype and pheno-
type. Furthermore, the endophenotype is 
associated with the disorder (i.e., present 
in affected individuals), but it also observ-
able in nonaffected first-degree relatives of 
an affected individual, since first-degree 
relatives are likely to carry some of the 
susceptibility genes of the disorder [3]. 
Fundamental to the endophenotypic con-
cept are the assumptions that the endophe-
notype is influenced by fewer genes than 
the phenotype and/or is less removed from 
relevant gene action than the phenotype, 
hence providing greater power for genetic 
analyses. Endophenotypes are not readily 
observable, unlike phenotypes, but require 
some sort of measurement. Candidate 
endophenotypes may be anatomical, 
neurochemical, neurophysiological or 
cognitive in nature.
The main objectives for including 
endophenotypes into genetic studies of 
psychiatric disorders are to unravel the 
modes of action of known risk genes and 
to discover new risk genes for the dis-
order. Additional advantages of studying 
endophenotypes instead of/or in addition 
to phenotypes are that endophenotypes 
can often be more objectively (and there-
fore reliably) measured than phenotypes 
and provide more insight into the neuro-
biological underpinnings of the disorder 
(and are, thus, more useful for creat-
ing animal models) than pheno types. 
Endophenotypes are more often quanti-
fiable instead of dichotomous phenotypes 
based on the Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-IV 
diagnostic categories (hence providing 
more statistical power). 
Given these advantages, it is surpris-
ing that research into candidate endo-
phenotypes for attention-deficit/hyper-
activity disorder (ADHD) lags somewhat 
behind, compared with similar studies 
in other psychiatric disorders, such as 
schizophrenia, (manic) depression and 
alcoholism. Perhaps this may be related 
to the disappointing findings of the first 
couple of ADHD endophenotype stud-
ies. These studies focused on cognitive 
functioning and examined several basic 
characteristics of an endophenotype, 
namely whether both affected children 
and their non affected family members 
performed worse than controls on cog-
nitive measures. One of the first stud-
ies that included (nonaffected) family 
members of ADHD patients was con-
ducted by Murphy and Barkley [4]. They 
observed that parents of children with 
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laboratory measures of sustained attention, memory, cognitive 
flexibility, encoding and impulsivity, despite showing impair-
ment in social and psychological functioning. Similar normal 
cognitive functioning was found in a large group of parents 
of ADHD children on tasks measuring set shifting, sustained 
attention and visual information processing [5]. These findings 
did not support the viability of cognitive functions as candidate 
endophenotypes for ADHD. However, given that symptoms 
of ADHD are predominantly present in childhood and often 
(strongly) improve during adolescence and adulthood, it may 
be more opportune to study endophenotypes in child siblings. 
One of the first studies that included nonaffected (nonreferred) 
siblings of children with ADHD was conducted by Seidman and 
colleagues [6]. Disappointingly, their findings also did not pro-
vide much confidence in finding cognitive ADHD endopheno-
types. They assessed executive, attention and memory functions 
in the children, and observed that siblings without ADHD were 
similar to controls on virtually all measures. They concluded 
that ‘neuropsychological deficits are unlikely to constitute an 
endophenotype to ADHD’. So far, not so good. 
“…support was found for temporal processing 
and/or response variability as candidate 
endophenotypes for ADHD…”
Perhaps the wrong cognitive functions were studied in search 
for candidate ADHD endophenotypes? In one of the most 
influential papers on candidate cognitive endophenotypes of 
ADHD, it was proposed that ADHD research should focus on 
three prime endophenotypic candidates: ‘a specific abnormality 
in reward-related circuitry that leads to shortened delay gradi-
ents, deficits in temporal processing that result in high intrasu-
bject intertrial variability, and deficits in working memory’ [3]. 
None of these functions were studied before as candidate endo-
phenotypes. It was only until recently (2007), that abnormali-
ties in reward-related circuitry were studied endophenotypi-
cally in a large sample of dizygotic twin pairs discordant for 
ADHD [7]. Motivation and delay aversion, two reward-related 
functions, were examined. Unexpectedly, both the group of 
affected children and the nonaffected siblings performed nor-
mally on the tasks, suggesting motivation and delay aversion 
were less suitable as endophenotypic candidates compared with 
the range of other functions examined in this study, such as 
executive functions, processing speed and response variability. 
More evidence for ADHD endophenotypic qualities has been 
gathered for temporal processing. In several studies, support 
was found for temporal processing and/or response variability 
as candidate endophenotypes for ADHD using widely differ-
ent tasks [7–12]. Similarly, support was found for verbal and 
visuospatial working memory as candidate endophenotypes 
for ADHD [7,8,13]. It, therefore, appears that two of the three 
suggested prime candidate cognitive endophenotypes [3] are 
supported by research results, yet more research is needed to 
confirm/depute abnormalities in reward-related circuitry as 
ADHD endophenotypes. 
Despite not being put forward as one of the three most likely 
ADHD endophenotypic candidates [3], inhibition (or interfer-
ence control) has been given the most attention from research-
ers aiming to detect cognitive ADHD endophenotypes [7,13–18]. 
Consistently, inhibition or interference control fulfilled the 
investigated basic characteristics of an endophenotype, such as 
being impaired in affected and nonaffected family members, 
and correlating between siblings. In addition, the brain activa-
tion during inhibition was similarly altered in ADHD-affected 
children and their nonaffected siblings. Thus, as with deficits 
in temporal processing and working memory, impaired inhibi-
tion or interference control can be considered a prime cognitive 
endophenotype for ADHD.
“…although informative, these initial 
endophenotypic studies may best be viewed as 
forming the basis from which more comprehensive 
studies must follow.”
Compared with the growing knowledge on cognitive endo-
phenotypes for ADHD, relatively little is known about neuro-
physiological and neuroimaging measures as candidate endo-
phenotypes for ADHD. Undoubtedly, this is related to the 
higher time and financial costs of these measures compared 
with the quickly and cheaply administered cognitive measures. 
Nevertheless, these measures are most likely worth the invest-
ment of extra time and money. For example, in a recent report 
on EEG measures in ADHD-affected sibling pairs [19], it was 
shown that EEG measures correlated moderately between sib-
lings during baseline conditions and significantly during cog-
nitive activation. Furthermore, specific event-related potential 
components related to action monitoring and initial error pro-
cessing were also found to be putative endophenotypes [20]. 
Neuroanatomical measures have also proved to be sensitive to 
familial ADHD effects. It was shown that nonaffected children 
had similar reductions in prefrontal and occipital gray and white 
matter as their affected siblings and also showed a trend towards 
having overall smaller brain volumes as did their affected sib-
lings [21]. Furthermore, orbitofrontal volume loss in ADHD 
was determined by genetic effects in a sample of monozygotic 
twin pairs concordant for ADHD [22], suggesting structural 
MRI (sMRI) measures have also proved a promising area for 
endophenotypic research. A recent study indicated that unaf-
fected siblings of individuals with ADHD show deficits similar 
to affected probands in prefrontal areas for unexpected events 
and in cerebellum for events at unexpected times [23]. Thus, 
although limited in number, the studies that have employed 
sMRI, functional MRI (fMRI) and neurophysiological mea-
sures provide support for the viability of such measures in the 
search for ADHD endophenotypes.
However, although informative, these initial endophenotypic 
studies may best be viewed as forming the basis from which 
more comprehensive studies must follow. These more compre-
hensive studies should incorporate information from all levels 
(i.e., genotype, endophenotype and phenotype) and aim at the 
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two main objectives for including endophenotypes into genetic 
studies of psychiatric disorders: unraveling the modes of action 
of known risk genes and discovering new risk genes for the 
disorder. Thus far, a multitude of studies has concentrated on 
the first aim. For example, the relationship between ADHD risk 
genes, such as the dopamine receptor 4 and 5 genes (DRD4 and 
DRD5, respectively) the dopamine transporter gene (DAT1), 
the monoamine-oxidase type A gene (MAOA), the catechol-O-
methyltransferase gene (COMT ), the dopamine β-hydroxylase 
gene (DBH ) and candidate endophenotypic measures (pre-
dominantly cognitive measures) have been studied. It is not my 
intention to systematically review all of these studies, but it is 
safe to say that results are, at best, inconsistent. Findings can 
often not be replicated or even reverse genetic effects on cogni-
tive functions are found [24]. Small sample sizes, differences 
in sample ascertainment (different ADHD subtypes, clinically 
referred or not and including controls or not), differences in 
used cognitive paradigms, differences in ADHD measurement 
methods (interview or questionnaires), differences in participant 
characteristics (e.g., age, sex and comorbidity) and differences 
in the studied polymorphisms may all hamper comparability 
between findings, limiting the possibility to unravel the modes 
of action of known risk genes. 
What about the second objective for including endopheno-
types into genetic studies of psychiatric disorders, namely to 
discover new risk genes for ADHD? In order to do this, link-
age analyses are necessary, which require substantial sample sizes 
to obtain adequate power. Thus far, only one study has been 
published using cognitive candidate ADHD endophenotypes 
in a linkage design [25]. However, results were promising. Two 
significant genome-wide linkage signals were found on 2q21.1 
and on 13q12.11, and ten additional suggestive linkage signals 
were found. The logarithm of the odds ratio scores of the two 
genome-wide significant linkage signals were among the highest 
ever reported in ADHD genetic research, supporting the use of 
endophenotypes to detect new risk loci. Similar promising find-
ings using endophenotypes in linkage have been reported by the 
Collaborative Study on the Genetics of Alcoholism [26].
“…the future of ADHD genetic studies looks 
promising, since endophenotype studies are 
increasingly comprehensively designed and are 
employing larger sample sizes than before.”
So, have endophenotypes in the genetic research of ADHD 
lived up to their expectations? Yes and no. Yes, because more and 
more is known about the mechanisms of action of ADHD risk 
genes by linking them to candidate ADHD endophenotypes. 
For example, well-designed studies, such as those conducted by 
Durston and colleagues [27], provide promising new leads into the 
modes of action of ADHD risk genes on brain activation patterns, 
which may, ultimately, translate into individualized treatments 
targeting genotype/fMRI activation profiles. No, because, as 
yet, no consistent pattern of findings on the modes of action 
of known risk genes has emerged from the current literature. 
However, compared with endophenotypic research in other fields 
(i.e., schizophrenia, [manic] depression and alcoholism), endo-
phenotypic research into ADHD is still in its primary phase. 
For example, candidate ADHD endophenotypes that emerge 
from literature comparing affected children and their nonaffected 
family members to controls may not always be true candidate 
endophenotypes. A comprehensive review on this issue has been 
published recently [28]. The authors state that a true candidate 
endophenotype mediates between genes and disorder. However, 
it may also be possible that the ‘candidate’ endophenotype fulfills 
several criteria of an endophenotype but, nevertheless, is not an 
endophenotype in the strict sense. For example, the ‘candidate’ 
endophenotype may actually be a consequence of the disease, may 
be an epiphenomenon (i.e., is related to the same gene[s] as the 
disorder but does not mediate between genes and disorder), may 
be related to entirely different genes than the disorder, or may 
arise from nongenetic factors. In the case that the trait is actually 
an epiphenomenon or related to environmental factors, it is pos-
sible that both ADHD patients and their nonaffected siblings will 
differ from controls [28], causing a false conclusion to be drawn on 
the usefulness of the trait as ADHD endo phenotype. Thus, future 
studies should try to determine whether a trait meets all relevant 
characteristics, as has been done comprehensively by Waldman 
and colleagues [29,30]. Nevertheless, the future of ADHD genetic 
studies looks promising, since endophenotype studies are increas-
ingly comprehensively designed and are employing larger sample 
sizes than before. 
“…candidate ADHD endophenotypes that emerge 
from literature comparing affected children and 
their nonaffected family members to controls may 
not always be true candidate endophenotypes.”
Several recommendations can be made for future ADHD endo-
phenotypic studies. First, substantially larger sample sizes are 
necessary to prevent spurious associations between risk genes 
and candidate endophenotypes. Second, ADHD involves wide-
spread cognitive disturbances, such as those of attention, execu-
tive functions, state regulation and motivation, motor control and 
temporal information processing [31]. These various functional 
domains can be associated with abnormal anatomic findings in 
brain regions implicated in these functions. Comprehensive endo-
phenotype batteries for ADHD must, therefore, assay all of these 
relevant variables, preferably in combination with sMRI, fMRI 
and/or neurophysiological measures. Third, it would greatly ben-
efit comparability of research findings when the same tasks are 
used across studies; that is, the current use of multiple variations 
of tests for the same cognitive domains prevents thorough gener-
alization of the research findings. Composing a freely accessible 
computer-driven battery with a broad range of tasks that have 
been examined for their validity, reliability and, preferably, for 
their heritability, would make it possible to combine different 
samples across research sites to a larger sample. This would greatly 
enhance comparability and power of genetic research results. 
Fourth, samples should preferably be studied longitudinally. The 
Expert Rev. Neurother. 8(10), (2008)1428
Editorial Rommelse
phenotypic presentation of ADHD and, possibly, also the genetic 
effects on candidate cognitive endophenotypic and phenotypic 
measures are strongly influenced by age [24,32]. These developmen-
tal effects can only be reliably studied in a longitudinal design. 
Fifth, comorbid disorders should be assessed in relation to genetic 
and endopheno typic variables of ADHD. Only in this way, light 
may be shed on the shared and unique developmental pathways 
leading up to ADHD with/without comorbidities. Moreover, 
hypothetically, what appears as a candidate ADHD endopheno-
type, may actually be an endophenotype of a comorbid disorder. 
For example, a recent study showed that increased response vari-
ability, considered a core cognitive feature of ADHD, was more 
strongly related to autism spectrum disorders than to ADHD [33]. 
Of course, this one study does not imply that increased response 
variability is not a viable ADHD endophenotype; however, 
such results do warrant the importance of studying ADHD in a 
broader phenotypic context. Taking into account these recom-
mendations will hopefully improve consistency among research 
results and, as such, increase our understanding into the genetic 
basis of ADHD. 
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